PA Job Availability Growing In Specialty Areas
Demand for PAs in medical and surgical subspecialties is increasing according to data from 2014 and 2016, reflecting the profession’s robust expansion from primary care.
Practice Management
PRACTICE MANAGEMENT
Featured Article
Latest News
Resumption of Athletic Activities in Pediatric Patients Following COVID-19 Infection
The American College of Cardiology has released guidance on pediatric return-to-play for sports participation following COVID-19 infection.
Patterns Changing for Heart Disorder Hospitalizations in Canada
Standardized hospitalization rates declined for coronary artery and vascular disease, heart rhythm disorders, stroke, and heart failure in Canada from 2007 through 2016.
![Treatments for JSpA are based on agents evaluated in adult SpA.[7,11] The 2011 ACR guidelines are for JIA and are not specific to JSpA.[11] The algorithms for peripheral disease consider the number of active joints and prognosis.[11] First-line treatment is essentially a brief trial of NSAID monotherapy. For persistent activity, the ACR suggests adding or switching to a disease-modifying anti-rheumatic drug (DMARD), such as methotrexate, sulfasalazine, or leflunomide. Glucocorticoid intraarticular injections are advised for all children with active arthritis.[11] DMARDs are effective for peripheral JIA but have not been proven effective for axial disease or enthesitis in JSpA.[7] However, open-label studies indicate sulfasalazine improves symptoms in juvenile AS, ERA, and PsA.[7] For JIA refractory to NSAIDs and DMARDs, ACR guidelines recommend a tumor necrosis factor (TNF) inhibitor.[11] The rate and type of treatment escalation depends on disease activity.[7]](https://3fvcugvijkt9bj7w3wf2t712-wpengine.netdna-ssl.com/wp-content/uploads/sites/17/2019/01/6prescriptionmedicationts1_1032644.jpg)
Electronic Health Records Fail to Detect Many Medication Errors
There is wide variation in the safety performance of electronic health record (EHR) systems used in U.S. hospitals.
Explaining Treatment Risks to Patients
Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”
Approximately 2 Million Americans Buy Prescriptions From Outside the Country
An estimated 1.5 percent of American adults purchase prescription medication from outside of the United States to save money.
Pfizer, BioNTech’s COVID-19 Vaccine Candidate Looks Promising in Early Human Trial
Pfizer and BioNTech SE announced positive preliminary results from the phase 1/2 study evaluating the safety, tolerability, and immunogenicity of escalating doses of the vaccine candidate BNT162b1 against COVID-19.
ACP: US Response to COVID-19 Identifies Inequalities in Health Care System
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
Apologies, Properly Made, Go Far in Maintaining Doctor-Patient Relationships
From an ethical perspective, disclosing adverse events to patients is predicated on the idea that physicians have obligations to tell the truth, but physicians may worry that apologizing will incur greater responsibility for liability.
Mobile App Unveiled to Aid in Epidemiologic COVID-19 Data Collection
In an effort to aid real-time epidemiology efforts, researchers have unveiled a mobile application called the COVID Symptom Tracker.
Telehealth Services Not Offered at Many US Hospitals
The American Hospital Association survey provided data to determine the availability of telemedicine services at US hospitals in 2019.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Practice Management
